FIA
OASM

FNY Investment Advisers’s Oasmia Pharmaceutical AB OASM Stock Holding History

FNY Investment Advisers’s Portfolio OASM Stock Details OASM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-2,600
Closed -$2K – 1318
2019
Q2 		$2K Buy
+2,600
New +$4.7K ﹤0.01% 862

FNY Investment Advisers's OASM Position: Q3 2019 in Review

FNY Investment Advisers sold out of Oasmia Pharmaceutical AB (OASM) in Q3 2019, closing a stake of 2,600 shares — an estimated $2K sold.

FNY Investment Advisers first reported a position in OASM in Q2 2019 and held it in 1 quarter. The position peaked at $2K in Q2 2019. 0 funds tracked by Wall St. Rank hold OASM as of Q3 2019.

  • FNY Investment Advisers reported no remaining Oasmia Pharmaceutical AB position as of Q3 2019 after selling out during the quarter.
  • FNY Investment Advisers sold 2,600 Oasmia Pharmaceutical AB shares in Q3 2019, an estimated $2K.
  • FNY Investment Advisers first reported a position in Oasmia Pharmaceutical AB in Q2 2019 and held it in 1 quarter.
  • FNY Investment Advisers's Oasmia Pharmaceutical AB position peaked at $2K in Q2 2019.
  • 0 funds tracked by Wall St. Rank held Oasmia Pharmaceutical AB as of Q3 2019.

Based on FNY Investment Advisers's 13F filing for Q3 2019, filed 25 Oct 2019.